Topic review

Innate Immunity in Breast Cancer

Subjects: Oncology & Oncogenics View times: 80
Submitted by: Israa Shihab

Definition

The innate immune system is the first line of defense against invading pathogens and has a major role in clearing transformed cells, besides its essential role in activating the adaptive immune system. Macrophages, dendritic cells, NK cells, and granulocytes are part of the innate immune system that accumulate in the tumor microenvironment such as breast cancer (BC). These cells induce inflammation in situ by secreting cytokines and chemokines that promote tumor growth and progression, in addition to orchestrating the activities of other immune cells. In breast cancer microenvironment, innate immune cells are skewed towards immunosuppression that may lead to tumor evasion. However, the mechanisms by which immune cells could interact with breast cancer cells are complex and not fully understood. Therefore, the importance of the mammary tumor microenvironment in the development, growth, and progression of cancer is widely recognized. With the advances of using bioinformatics and analyzing data from gene banks, several genes involved in NK cells of breast cancer individuals have been identified.

1. Breast Cancer Heterogeneity and the Role of Immune Cells

Among all types of cancer, breast cancer is the most frequent type in women worldwide. Each year, this malignancy affects more than two million women globally, which is the primary cause of death [1]. In 2018, it is estimated that 627,000 women died from breast cancer, approximately 12% of all cancer deaths among women [2]. Despite the advances in management strategies in diagnosis and treatment, the high heterogeneity of this cancer makes it difficult to treat. Breast cancer (BC) can be histologically classified to luminal A, luminal B, Her2 positive, basal-like, and normal-like, with respect to the biomarkers status of estrogen receptor (ER), progesterone receptor (PR), and HER2 [3][4]. It has been found that triple negative breast cancer is the most aggressive and has the lowest overall survival rate between other types of breast cancer [5]. Besides, the tumor microenvironment (TME) plays a dual role in tumor progression and immune repression. The tumor microenvironment influences immune cells to be activated and differentiated towards enhancing tumor progression and favors inhibition of anti-tumor activities. However, the complete interaction between breast cancer cells and the immune cells in the tumor microenvironment is not very well understood [6][7].

The cells of the immune system that are implied in the immune defense are components of either the innate or the adaptive immune system. The first early response to a pathogen or transformed cells is a function of the innate immune cells that act rapidly and non-specifically to an attack to prevent spreading of the foreign pathogen [8]. The cells of the innate immune system control and clear invasion via various mechanisms, such as release of cytotoxic molecules, engagement of more immune cells, complement pathway activation, or activation of the phagocytosis process [9]. In cancer, tumor cells may release some cellular components that may activate the innate immune cells, which in turn establish antitumor immunity in the microenvironment and hence induce tumor eradication [10][11].

The activation of innate immune cells results in the interplay of events that work together to control and destroy tumor cells. For instance, upon encounter with transformed tumor cells, some immune cells such as macrophages and dendritic cells become activated and release large amounts of pro-inflammatory cytokines such as IL-12, IL-15, and type 1 interferon (IFN) that activate natural killer (NK) cells and T helper cell differentiation [12][13]. The activation of innate cells in turn stimulates adaptive immune system by releasing large amounts of IFN-γ and chemokines including CCL3 and CCL4 [14][15][16]. In addition, the release of IFN-γ and IL-12 is necessary to destroy tumor cells by switching anti-inflammatory M2 to M1 phenotype, along with an increase of MHC I molecules on tumor cells [17][18]. Therefore, understanding the cross talk among these cell types and tumor cells can advance the knowledge of how immune cells infiltrate into the tumor microenvironment, which may help in choosing the best personalized immunotherapy therapeutic approaches.

2. Components of the Tumor Microenvironment

Apart from tumor cells present in breast cancer, the tumor microenvironment (TME) contains other cells such as fibroblasts and immune cells, extracellular matrix (ECM), blood vessels, and some signaling molecules [19]. TME is important for tumor angiogenesis, immune cells’ inhibition, escape from immune surveillance, as well as tumor proliferation and survival. ECM plays a major role in breast cancer microenvironment, as it provides the physical support to solid tumors by its protein components such as collagen and proteoglycan. Additionally, ECM is rich in several growth factors that can regulate angiogenesis and inflammation [20]. In advanced stages, ECM becomes disrupted and dysregulated allowing tumor growth by metalloproteinases (MMPs), aiding in cells migration from or into the TME, and thus assisting tumor metastasis [21][22].

In addition to ECM disruption, rapid growing tumors lack sufficient blood supply, creating a hypoxic and acidic environment. This environment will induce tumor cells to release vascular endothelial growth factor (VEGF) and other angiogenic molecules, causing the formation of new blood vessels from the existing vessels for the tumor[23][24], as shown in Figure 1. Furthermore, the newly formed vessels have irregular wall layers, making them leaky with disrupted blood flow, thus providing inadequate blood and nutrient supply that further enhances angiogenesis and tumor growth [25][26].

TME makes a niche for the proliferation of tumor cells and the neighboring different types of cells such as endothelial and immune cells. The interaction between cancer cells and immune cells promotes modifications in the tumor microenvironment, which induce tumor angiogenesis, growth, progression, and metastasis [27][28]. Moreover, immune cells secrete chemokines and cytokines that attract other cells into the microenvironment, consequently contributing to tumor progression [29]. The immune cells could inhibit or promote tumor growth and their possible dual roles have been previously investigated intensively. For instance, immune suppressive TME has been reported to be essential for tumor survival and growth. Indeed, the importance of immune cells is illustrated by the fact that chronic inflammation correlates with a higher chance of tumor incidence [30]. For this reason, innate immune cells present in the tumor microenvironment such as macrophages, myeloid-derived suppressive cells (MDSC), and neutrophils are associated with immunosuppression, poor prognosis, and tumor progression [31]. On the other hand, the presence of other innate immune cells such as NK cells in TME indicates good prognosis and tumor clearance. Therefore, understanding the TME development and its components, as well as the interaction between various cell types in TME is quite crucial for development and progress of breast cancer (Figure 1).